The U.S. Senate Finance Committee’s latest drug pricing legislation includes 340B language not seen before in earlier House and Senate versions.
Senate Finance Committee’s New Drug Pricing Text Includes a New 340B Provision
The U.S. Senate Finance Committee’s latest drug pricing legislation includes language, not seen before in earlier House and Senate versions, about denying 340B covered entities’ access to government-negotiated lower prices on drugs covered under Medicare.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.